Inquiry
메인콘텐츠 바로가기 주요메뉴 바로가기
하이로닉 로고

하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.

인터내셔널 웹사이트 →

It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.

International Website →
닫기
하이로닉 로고

하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

US 웹사이트 →

It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

US Website →
닫기
하이로닉 로고

하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

EU 웹사이트 →

It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

EU Website →
닫기

With 20 years of accumulated energy-based technologies' development and a fresh perspective,
we are creating the next standard in medical aesthetics.

FIRSTS
Brand Story

The Record
of Firsts

Our innovation aims
for world firsts.

Founded in 2006, HIRONIC has introduced a number of medical aesthetic solutions never before seen in the market, driven by a relentless pursuit of new technologies. Our record of world firsts is more than a simple achievement — it reflects HIRONIC's commitment to proving better results.

01

Asia's First HIFU

Developed Asia's first
HIFU for skin treatment

02

Women’s HIFU

Developed the world's first
HIFU for women's health

03

Home HIFU

Developed the world's
first at-home HIFU

04

2nd Generation Microwave

Developed the world's first
Focused Intensive Microwave

20+ Years of technology and efficacy
History

Our History

A record of the path we have walked together and the future we are moving toward.

2026
Launched MIGLOU™, a 2.45GHz focused microwave device
Celebrated 20th anniversary
2025
Launched SYNERJET PRO™, a synergy microjetting device
Surpassed 5,700 cumulative units sold across the HIFU product line
2024
SILKRO™ received U.S. FDA approval
HIRONIC selected as one of the Global Leading Companies 1000+
2023
Achieved KRW 30 billion in revenue
Subsidiary Attibe Beauty achieved KRW 10 billion in revenue
2022
Selected as World-Class Products: NEW DOUBLO™, ULTRAVERA™, DOUBLO GOLD™
Osong Factory 2 obtained GMP certification for medical device manufacturing
2021
Launched NEW DOUBLO™, the first HIFU+RF synergy device
PICOHI™ obtained European CE MDD certification and U.S. FDA approval
2020
SLIMUS™ received U.S. FDA approval
ULTRA VERA™ obtained CE MDD certification
2019
Launched PICOHI™, a 300ps pico laser
Won the Minister of Trade, Industry and Energy Award
2018
A-FIT™ received U.S. FDA approval
SLIMUS™ won the Good Design Award
2017
Launched SLIMUS™, a non-invasive 1060nm diode laser fat reduction device
Surpassed 2,000 units sold in the DOUBLO™ series
2016
Relocated headquarters to Dongcheon-dong, Suji, Yongin
Received the Minister of Trade, Industry and Energy Commendation
2015
Received the USD 10 Million Export Tower Award
Received the Presidential Commendation for Contribution to Venture Business Promotion
2014
Listed on KOSDAQ
Won the Presidential Award in Technology Innovation
2013
Listed on KONEX
Launched DOUBLO-S™
2012
Received the USD 3 Million Export Tower Award
DOUBLO™ selected as a Next-Generation World-Class Product
2011
Launched DOUBLO™, Asia's first HIFU for skin treatment
Received the USD 1 Million Export Tower Award
2010
Selected as a Gyeonggi-do e-Frontier Company
2009
Obtained ISO 9001 and ISO 13485 certifications
Obtained KGMP certification
2008
Established HIRONIC company
2006
Established SP MEDICAL company — the beginning of HIRONIC
Mission & Vision

Mission &
Vision

We contribute to our customers and society through innovative technology.

Mission

We contribute to customers and society through innovative aesthetic medical devices.

Vision

Become the global No.1 in the aesthetic medical device industry by 2030, achieving the highest customer satisfaction.

01

Commitment
to Mission

02

Customer
First

03

Devotion
to Future

04

Focus on
Innovation

HIRONIC Product

Our
Products

A medical aesthetics portfolio built on innovative energy-based technologies

HIRONIC offers a product portfolio tailored to the needs of clinics, hospitals, and customers, based on a wide range of energy-based technologies including HIFU, RF, MICROWAVE, LASER, PLASMA, and NEEDLE-FREE DELIVERY.

HIFU + RF

NEW DOUBLO

The synergy of HIFU/MFU and RF in one device for ultimate skin lifting

View Product
Microwave

MIGLOU

Face-to-body care with 2.45GHz Focused Intensive Microwave technology

View Product
Needle-Free

SYNERJET PRO

Needle-free delivery based on the synergy of Microjetting, Electroporation, and Cold Plasma

View Product
300ps Laser

PICOHI

A 300 picosecond laser platform for pigmentation, skin tone, and skin quality care

View Product
HIRONIC From CEO

For the past 20 years, HIRONIC has worked to bring the value of technology and innovation closer to medical aesthetics practices around the world.

HIRONIC not only pioneered the market as a trailblazer of HIFU technology in Asia, but also opened new possibilities for the global medical aesthetics market with world-first innovations such as women's HIFU and at-home HIFU. We did not stop there — going beyond focused ultrasound, we developed MIGLOU™, a second-generation microwave lifting device, and are expanding the experience of beauty in new ways.

We believe aesthetics is not simply a choice for outward change.

Aesthetics is a process of looking deeper into oneself, restoring lost confidence, and finding one's own unique beauty. For some, a small change can transform their daily expression; for others, it can become the start of loving themselves again.

HIRONIC has grown alongside medical professionals across the globe so that this journey toward beauty can be safer, more comfortable, and more trustworthy. From product training and clinical support to marketing solutions and after-sales service, we strive to be the closest partner in every moment of aesthetic practice — in every market we serve.

CEO, HIRONIC
Jinu Lee Jinu Lee Sign
HIRONIC CEO Jinu Lee
Press & Media

Media
Archive

Explore HIRONIC's technology and brand story through media.

View All Press

HIRONIC Marks 20th Anniversary

HIRONIC marked the 20th anniversary of its founding on July 12, 2026. The company was established in 2006 as SP Medical, a name derived from "Success Partner," and has since grown into a KOSDAQ-listed developer and manufacturer of medical aesthetic devices with a presence in more than 60 countries. Two Decades of Development HIRONIC's founding period (2006–2010) centered on the development of its first medical devices and the establishment of its early patent portfolio. Between 2011 and 2016, the company listed on KOSDAQ and introduced the DOUBLO line of devices, a technology platform later upheld through a defended patent ruling. From 2017 to 2020, HIRONIC received FDA and CE approvals for multiple device lines, expanding its distribution beyond the Korean market. The period from 2021 to 2023 saw continued growth in international distribution and industry recognition. Most recently, the company has launched SYNERJET PRO™ and MIGLOU™, both of which have received Korea MFDS approvals in 2026. Current Operations HIRONIC's product portfolio today includes SYNERJET PRO™, MIGLOU™, New Doublo™ (marketed in Korea as V-RO LIFTING™​), and PICOHI™, covering applications in skin treatment, body contouring, and related aesthetic procedures. The company continues to work with distributors and physicians across its international markets. In a statement marking the anniversary, HIRONIC said the milestone reflects two decades of work with its distributors, partner physicians, and patients, and that the company intends to continue developing new devices and expanding its international regulatory approvals in the years ahead.​ 

HIRONIC's MIGLOU™ Receives MFDS Approval, Expanding Its Focused Intensive Microwave Platform for the Global Aesthetic Market

HIRONIC, a global medical aesthetic device company marking its 20th anniversary in 2026, announced today that its MIGLOU™ device has received medical device approval from Korea's Ministry of Food and Drug Safety (MFDS). The approval adds MIGLOU™ to HIRONIC's growing portfolio of MFDS-certified technologies, reinforcing the company's continued investment in clinically validated, next-generation aesthetic solutions for medical professionals worldwide.    A New Approach to Skin Tightening and ContouringMIGLOU™ is built on HIRONIC's proprietary 2.45GHz Focused Intensive Microwave (FIM) technology, engineered to deliver targeted energy for skin tightening and contouring treatments. The platform reflects HIRONIC's ongoing commitment to developing differentiated technologies that address evolving needs in the medical aesthetics field. The approval marks another step in HIRONIC's 20th anniversary year, reflecting the company's continued focus on research-driven development and a regulation-first approach to bringing new technologies to the global aesthetic market.Strengthening HIRONIC's Global Technology PortfolioThe MFDS approval positions MIGLOU™ alongside HIRONIC's established device lines — including New Doublo™, SYNERJET PRO™​, and PICOHI™  — as part of a comprehensive technology platform serving medical aesthetic partners in more than 60 countries. With MFDS, FDA, and CE certifications across its portfolio, HIRONIC continues to expand its footprint through a rigorous, regulation-first approach to product development.About HIRONICFounded in 2006, HIRONIC is a KOSDAQ-listed medical aesthetic device company celebrating its 20th anniversary in 2026. HIRONIC develops and manufactures energy-based aesthetic devices distributed across more than 60 countries, with a portfolio spanning HIFU, RF, laser, and needle-free delivery technologies.  

HIRONIC Showcases Flagman Device Lineup at IMCAS Asia 2026 in Bangkok

HIRONIC took part in IMCAS Asia 2026 (19th Edition), one of Asia's most prestigious aesthetic medicine conferences, held June 19–21 at The Athenee Hotel, Bangkok. In cooperation with Thai partner, HIRONIC presented its latest innovations in energy-based aesthetic devices to a global audience of practitioners and industry experts. A Showcase of HIRONIC's Core TechnologiesAt the booth, HIRONIC introduced three key devices spanning the company's core treatment categories: PICOHI™, HIRONIC's picosecond laser platform for pigmentation and skin revitalization; SYNERJET PRO™, the brand's needle-free triple-action delivery platform combining microjetting, electroporation, and cold plasma; and the flagship New Doublo™, HIRONIC's advanced MFU+RF platform for lifting and skin tightening. Together, the lineup gave attendees a comprehensive look at how HIRONIC's technologies address needs across skin pigmentation, scar remodeling, and skin tightening.  Expert Lecture Spotlights MIGLOU™'s Proprietary FIM TechnologyA highlight of the conference was the Expert Lecture delivered by Dr. Thitikom Limrattanamekha, held during the Laser & EBD Session at The Athenee Hotel. In his presentation, "MIGLOU™ 2.45 GHz: Precision UHF Technology for Non-Invasive Fat Lipolysis and Contouring," Dr. Thitikom outlined the clinical advantages of MIGLOU™'s focused intensive microwave (FIM) technology — a modality proprietary to HIRONIC and the first of its kind in the world. His lecture detailed how MIGLOU™'s precision UHF approach enables non-invasive fat lipolysis and body contouring with a distinct mechanism of action compared to existing energy-based technologies, drawing strong engagement from attending practitioners. Strengthening HIRONIC's Presence in Southeast AsiaIMCAS Asia 2026 offered HIRONIC an important opportunity to deepen its relationship with practitioners across Southeast Asia. As HIRONIC celebrates its 20th anniversary in 2026, events like IMCAS Asia continue to play a key role in the company's global expansion strategy, connecting its technologies with the clinicians and markets shaping the future of aesthetic medicine. HIRONIC thanks Dr. Thitikom Limrattanamekha for his insightful lecture, its Thai partner for their continued collaboration, and all attendees who visited our booth during the conference. For more information about PICOHI™, SYNERJET PRO™, New Doublo™, or MIGLOU™, please visit our website or contact your regional HIRONIC representative.  

HIRONIC Hosts VVIP Private Launch Preview for Korea and Japan's Top Aesthetic Experts

Last Saturday, HIRONIC welcomed an elite audience of leading aesthetic experts and top users from Korea and Japan for a private launching preview — an intimate, high-level event dedicated to unveiling two groundbreaking new devices set to redefine the non-invasive aesthetics landscape. Two Landmark Innovations UnveiledThe event introduced two next-generation devices: an advanced contouring and face lifting platform powered by microwave technology, available for export as MIGLOU™, and a revolutionary needle-free injector that uniquely combines three technologies — micro-jetting, electroporation, and plasma — in a single platform, available for export as SYNERJET PRO™.Four Immersive Expert LecturesThe launch was enriched by four in-depth lectures delivered by four of Korea's foremost aesthetic experts, offering clinical insights, hands-on perspectives, and forward-looking analysis on both devices and the broader direction of non-invasive aesthetics.Expert Insights on HIRONICAcross the presentations, experts consistently highlighted what sets HIRONIC apart in a crowded market. HIRONIC devices are recognized for their exceptional build quality, and the brand has remained steadfastly focused on non-invasive technologies — always prioritizing reduced patient discomfort alongside improved clinical efficacy. It is this unwavering philosophy, experts noted, that allows HIRONIC devices to consistently outperform competitors.A New Standard in Microwave-Based ContouringOn the microwave contouring device, experts drew particular attention to its proprietary FIM (Focused Intensive Microwave) technology — a uniquely advanced feature that enhances treatment efficiency while delivering the same energy output. This innovation, experts emphasized, is an entirely distinctive advancement that elevates MIGLOU™ (export name) to true second-generation microwave technology status, setting it apart from all currently available solutions and creating clear, immediate market value.Redefining Needle-Free DeliveryRegarding the triple-technology needle-free injector, experts were equally emphatic: combining micro-jetting, electroporation, and plasma into a single device is not incremental progress — it is a meaningful leap forward. When these three technologies work in synergy, they significantly enhance active ingredient absorption, a benefit now supported by recent clinical studies. Experts underscored that SYNERJET PRO™ (export name) directly overcomes the limitations of currently available needle-free solutions, positioning it as an undeniable step toward shifting the aesthetics industry from the injection era into a new age of advanced needle-free delivery.Setting the Course for the Future of Non-Invasive AestheticsThe private launch preview was more than a product reveal — it was a statement of direction. With two devices that each advance their respective categories in meaningful, clinically relevant ways, HIRONIC once again demonstrated its commitment to pushing the boundaries of non-invasive aesthetics. As both platforms make their way to markets worldwide, the industry will be watching closely — and if the response from Korea and Japan's top experts is any indication, the impact is set to be significant.​

HIRONIC Signs Exclusive Supply Agreement with EMAGE Medical in the U.S. for “Next-Generation RF Combination Platform”

HIRONIC announced on May 15 that it has signed an exclusive supply agreement with EMAGE Medical, a U.S.-based medical device distribution company, for its “next-generation RF combination platform” in the United States.The agreement will be carried out under an OEM model and will remain valid for two years from May 2026. The contract is also structured to allow an extension through mutual agreement between the two companies.EMAGE Medical is a medical device distribution company headquartered in Charlotte, North Carolina, and has established specialized medical aesthetic sales channels in the United States. During the contract period, EMAGE Medical plans to supply HIRONIC’s platform device under a locally customized brand, based on its exclusive sales and distribution rights across the U.S. market.The agreement includes a minimum annual purchase quantity clause. According to the company, this provision is intended to ensure active sales activities by the partner company. At the same time, the agreement includes conditions allowing the minimum purchase obligation to be adjusted in consideration of regulatory changes, including the FDA approval timeline, thereby balancing risk management for both parties.Based on technical and regulatory cooperation with EMAGE Medical, HIRONIC will support the local brand launch in the United States. The company also plans to build clinical case data and establish a network of key opinion leaders, or KOLs.The “next-generation RF combination platform” is characterized by the integration of RF, or radiofrequency, and Cold Plasma technologies into a single device. With five types of handpieces, including RF microneedling, Cold Plasma, and Circle monopolar RF, the platform supports a wide range of clinical applications, including skin lifting, tightening, scar and wrinkle improvement, and women’s health.In particular, the company explained that the sequential combination protocol using RF microneedling and Cold Plasma is designed to enhance collagen activation while minimizing post-procedure inflammation.A HIRONIC official stated, “This exclusive supply agreement in the United States, the world’s largest medical aesthetic market, demonstrates that our technology has been recognized in the global market.” The official added, “We will continue to strengthen our competitiveness in the medical aesthetic market by enhancing our technological capabilities and expanding strategic partnerships.” Reporter: Seong-hye Kim, hankyung.com[shkimmy@hankyung.com]Translation of the original articleOriginal article link: https://www.hankyung.com/article/202605158616O​